Wu Yiling, member of CPPCC, calls to enhance research and development of TCM and promote its industrialization in his proposal to the CPPCC. Wu is also an academician of Chinese Academy of Engineering and head of a pharmaceutical company.

The annul CPPCC session officially kicks off on Wednesday (March 03).

Japan and South Korea import herbal materials from China at low prices and process the materials with well-developed technologies.

The international herbal medicine market is developing very fast, but China, the birth place of TCM, only accounts for three to five percent of the market.

Wu lists the existing problems in China's TCM industry in his proposal, such as weak research power, inflexible system and lack of competitiveness.

He suggests improving the status quo by innovation, cultivating able talents and strengthening R&D power.